Eun Ju Shin

Title: Eun Ju Shin - Innovator in Pharmaceutical Science

Introduction

Eun Ju Shin is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for various medical conditions. Her work focuses on enhancing the efficacy and half-life of therapeutic agents.

Latest Patents

Eun Ju Shin holds a patent for a fusion polypeptide that contains a glucagon-like peptide (GLP) and an immunoglobulin hybrid Fc. This invention is particularly noteworthy as it offers an increased half-life and improved efficacy compared to conventional fusion polypeptides. The fusion polypeptide is designed for use in treating diabetes, inflammatory bowel disease, endoenteritis, diarrhea caused by anticancer chemotherapy, and short bowel syndrome. The enhanced resistance to the DPP-4 enzyme makes this fusion polypeptide a promising candidate for pharmaceutical applications.

Career Highlights

Eun Ju Shin is currently employed at Genexine, Inc., where she continues to advance her research and development efforts. Her innovative approach to drug formulation has positioned her as a key figure in the pharmaceutical industry.

Collaborations

Eun Ju Shin collaborates with notable colleagues, including Young Chul Sung and Se Hwan Yang. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Eun Ju Shin's work exemplifies the impact of innovation in the pharmaceutical field. Her contributions are paving the way for more effective treatments for serious medical conditions.